TLR4 signaling and hypoxia are shown to contribute to the regulation of EMT in HCC cells, with TLR4+ cells exhibiting a more mesenchymal- and cancer stem cell (CSC)-like phenotype that is associated with more aggressive disease [56,81]. This evidence concerns the gene TLR4 and cancer.